CHUGAI-PHARMABODY.COM
Chugai PharmabodyGlobal Chugai News Release. Tuesday, 20 March 2018 6:00 AM. Long-Acting Erythropoiesis Stimulating Agent MIRCERA Injection Syringe 12.5μg Approved in Japan. Friday, 16 March 2018 6:45 AM. Chugai Decided as 2017 Tokyo Sports Promotion Model Company. Friday, 16 March 2018 6:00 AM. Chugai Starts Activities towards Commercialization of Foundation Medicine’s Products in Japan - Chugai Enters a License Agreement with Roche and Submits for Regulatory Approval of FoundationOne CDx™ -. 3 Biopolis Drive,.
http://www.chugai-pharmabody.com/


